Skip to main content
. 2021 May 26;11:665192. doi: 10.3389/fonc.2021.665192

Table 1.

The correlation between clinicopathological variables and METTL18 expression.

Characters level Low expression of METTL18 High expression of METTL18 p test
n 186 185
T stage (%) T1 99(53.8%) 82(44.6%) 0.206 exact
T2 42(22.8%) 52(28.3%)
T3 39(21.2%) 41(22.3%)
T4 4(2.2%) 9(4.9%)
N stage (%) N0 121(98.4%) 131(98.5%) 1.000 exact
N1 2(1.6%) 2(1.5%)
M stage (%) M0 128(99.2%) 138(97.9%) 0.624 exact
M1 1(0.8%) 3(2.1%)
Pathologic stage (%) Stage I 94(53.7%) 77(44.8%) 0.396 exact
Stage II 40(22.9%) 46(26.7%)
Stage III 39(22.3%) 46(26.7%)
Stage IV 2(1.1%) 3(1.7%)
Residual tumor (%) R0 167(96.0%) 157(93.5%) 0.390 exact
R1 7(4.0%) 10(6.0%)
R2 0(0.0%) 1(0.6%)
Histologic grade (%) G1 33(17.9%) 22(12.1%) <0.001
G2 105(57.1%) 72(39.6%)
G3 39(21.2%) 83(45.6%)
G4 7(3.8%) 5(2.7%)
Gender (%) Female 60(32.3%) 61(33.0%) 0.912 exact
Male 126(67.7%) 124(67.0%)
Race (%) Asian 63(35.4%) 95(52.5%) 0.003 exact
Black or African American 8(4.5%) 9(5.0%)
White 107(60.1%) 77(42.5%)
Adjacent hepatic tissue inflammation (%) Mild 44(35.8%) 55(49.5%) 0.076
None 70(56.9%) 47(42.3%)
Severe 9(7.3%) 9(8.1%)
Child-Pugh grade (%) A 113(91.1%) 104(90.4%) 0.907 exact
B 10(8.1%) 11(9.6%)
C 1(0.8%) 0(0.0%)
Vascular invasion (%) No 110(68.3%) 96(62.3%) 0.318
Yes 51(31.7%) 58(37.7%)
Tumor status (%) Tumor free 109(62.3%) 92(52.0%) 0.053 exact
With tumor 66(37.7%) 85(48.0%)
TP53 status (%) Mut 42(23.3%) 60(33.7%) 0.040
WT 138(76.7%) 118(66.3%)
Age (%) <=60 87(46.8%) 90(48.9%) 0.758
>60 99(53.2%) 94(51.1%)
AFP (ng/ml) (%) <=400 117(82.4%) 96(70.6%) 0.029
>400 25(17.6%) 40(29.4%)